Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease.

Kathleen Luskin, Hiral Thakrar, Andrew White

Immunology and allergy clinics of North America 2020 May

filter terms:

Aspirin-exacerbated respiratory disease (AERD) is characterized by eosinophilic chronic rhinosinusitis with nasal polyps, asthma, and upper-/lower-respiratory tract reactions to nonsteroidal antiinflammatory drugs. Persistent, severe disease, anosmia, and alcohol sensitivity is typical. AERD is mediated by multiple pathways, including aberrant arachidonic acid metabolism leading to elevated leukotriene E4 and decreased prostaglandin E2. Mast cell mediators (prostaglandin D2) and unique properties of eosinophils and type 2 innate lymphoid cells, along with receptor-mediated signaling, also contribute to AERD pathogenesis. Pharmacologic therapies are a cornerstone of AERD treatment and include leukotriene modifiers, corticosteroids, biologics, and aspirin. Copyright © 2019 Elsevier Inc. All rights reserved.

Citation

Kathleen Luskin, Hiral Thakrar, Andrew White. Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease. Immunology and allergy clinics of North America. 2020 May;40(2):329-343